Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization. 1979

S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond

Sixty-eight strains of capnophilic fusiform Gram-negative rods from the human oral cavity were subjected to extensive physiologic characterization, tested for susceptibility to various antibiotics, and the mol-percent guanine plus cytosine of each isolate determined. The characteristics of the isolates were compared with 10 fresh and 2 stock isolates of Fusobacterium nucleatum. The isolates clearly differed from the Fusobacterium species on the basis of mol-percent guanine plus cytosine, end products, growth in a capnophilic environment and fermentation of carbohydrates. All of the gliding isolates required CO2 and formed acetate and succinate, but not H2S, indole or acetylmethylcarbinol. All fermented glucose, sucrose, maltose and mannose. The organisms may be differentiated on the basis of fermentation of additional carbohydrates, hydrolysis of polymers and reduction nitrate. Three species are proposed: Capnocytophaga ochracea, Capnocytophaga sputigena and Capnocytophaga gingivalis. Ten isolates did not fit into the proposed species.

UI MeSH Term Description Entries
D010518 Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) Pericementitis,Pericementitides,Periodontitides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D003773 Dental Plaque A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms. Plaque, Dental
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D005673 Fusobacterium A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections. Sphaerophorus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
July 1979, Archives of microbiology,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
March 1981, Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
December 1979, Infection and immunity,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
May 1979, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
February 1977, Journal of clinical microbiology,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
October 1979, Infection and immunity,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
August 1975, The British journal of dermatology,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
January 2010, Current topics in medicinal chemistry,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
May 1950, Orvosi hetilap,
S S Socransky, and S C Holt, and E R Leadbetter, and A C Tanner, and E Savitt, and B F Hammond
May 2000, Trends in microbiology,
Copied contents to your clipboard!